Sugi Predict
/ Targets
/ GGCT
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to GGCT by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) |
PHASE4 | UNKNOWN |
| Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer |
PHASE3 | COMPLETED |
| InDACtion vs 3+7 Induction in AML |
PHASE3 | UNKNOWN |
| Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer |
PHASE2 | NOT_YET_RECRUITING |
| A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction |
PHASE2 | COMPLETED |
| Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia Vera |
PHASE2 | COMPLETED |
| Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy |
PHASE2 | ACTIVE_NOT_RECRUITING |
| Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects |
PHASE2 | RECRUITING |
| Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial) |
PHASE2 | RECRUITING |
| HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy |
PHASE2 | ACTIVE_NOT_RECRUITING |
| First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma |
PHASE2 | COMPLETED |
| Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma |
PHASE2 | RECRUITING |
| Serine Supplementation for Obese Subjects With Fatty Liver Disease |
PHASE1/PHASE2 | COMPLETED |
| Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis |
PHASE1 | COMPLETED |
| A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease |
PHASE1 | COMPLETED |
| Tolerability of Enteral NAC in Infants |
PHASE1 | NOT_YET_RECRUITING |
| A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease |
PHASE1 | COMPLETED |
| A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma |
PHASE1 | ACTIVE_NOT_RECRUITING |
| ThisCART19A for B-NHL Relapsed After Auto-CAR T |
PHASE1 | UNKNOWN |
| Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults |
PHASE1 | NOT_YET_RECRUITING |
| A Study of MCARH109 and MCARH125 in People With Multiple Myeloma |
PHASE1 | ACTIVE_NOT_RECRUITING |
| High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia |
nan | COMPLETED |
| Acute Glycine Pharmacodynamic Study |
nan | COMPLETED |
| Broccoli and Vascular Health Study |
nan | COMPLETED |
| Congenital Hemolytic and Dyserythropoietic Anemias |
nan | RECRUITING |
| Review of French Cases of Glutathione Synthetase Deficiency |
nan | UNKNOWN |
| Cause of Familial Testicular Cancer |
nan | COMPLETED |
| Genetics of Familial Testicular Cancer |
nan | COMPLETED |
| Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients |
nan | UNKNOWN |
| The Conversion of ENcapsulated GlucorAphanin, Gut Microbiota Phylogeny and gEnotype Study (ENGAGE) |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a GGCT binder may also engage these)